Plexus (NASDAQ:PLXS) Releases Quarterly Earnings Results, Misses Estimates By $0.55 EPS

by · The Cerbat Gem

Plexus (NASDAQ:PLXS – Get Free Report) issued its quarterly earnings results on Wednesday. The technology company reported $1.58 EPS for the quarter, missing analysts’ consensus estimates of $2.13 by ($0.55), Zacks reports. The business had revenue of $1.30 billion for the quarter, compared to analysts’ expectations of $1.23 billion. Plexus had a net margin of 4.35% and a return on equity of 12.84%. During the same period in the previous year, the business posted $1.64 earnings per share. Plexus updated its Q4 2026 guidance to 2.470-2.630 EPS.

Plexus Stock Performance

Shares of NASDAQ:PLXS traded down $9.59 during mid-day trading on Wednesday, reaching $240.49. The company had a trading volume of 825,119 shares, compared to its average volume of 336,020. The company has a current ratio of 1.54, a quick ratio of 0.74 and a debt-to-equity ratio of 0.06. The firm has a market cap of $6.44 billion, a price-to-earnings ratio of 35.16 and a beta of 0.88. The company’s 50-day moving average price is $274.29 and its 200-day moving average price is $232.49. Plexus has a one year low of $124.49 and a one year high of $307.06.

Insider Activity at Plexus

In other Plexus news, insider Victor (Pang Hau) Tan sold 3,000 shares of the firm’s stock in a transaction on Monday, May 11th. The stock was sold at an average price of $271.23, for a total value of $813,690.00. Following the completion of the sale, the insider directly owned 10,457 shares of the company’s stock, valued at $2,836,252.11. This trade represents a 22.29% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through this link. Also, EVP Angelo Michael Ninivaggi, Jr. sold 3,270 shares of the business’s stock in a transaction on Friday, May 8th. The shares were sold at an average price of $264.75, for a total value of $865,732.50. Following the completion of the sale, the executive vice president owned 16,266 shares in the company, valued at approximately $4,306,423.50. The trade was a 16.74% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Over the last quarter, insiders have sold 20,481 shares of company stock worth $5,519,183. Insiders own 1.78% of the company’s stock.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently made changes to their positions in the company. Dimensional Fund Advisors LP increased its holdings in Plexus by 0.5% in the 4th quarter. Dimensional Fund Advisors LP now owns 1,373,457 shares of the technology company’s stock worth $201,903,000 after acquiring an additional 7,051 shares during the last quarter. State Street Corp lifted its holdings in Plexus by 2.3% during the second quarter. State Street Corp now owns 1,059,501 shares of the technology company’s stock valued at $143,361,000 after purchasing an additional 24,115 shares during the last quarter. Fuller & Thaler Asset Management Inc. lifted its holdings in Plexus by 5.8% during the fourth quarter. Fuller & Thaler Asset Management Inc. now owns 446,705 shares of the technology company’s stock valued at $65,666,000 after purchasing an additional 24,441 shares during the last quarter. Nuveen LLC boosted its position in Plexus by 12.2% during the fourth quarter. Nuveen LLC now owns 390,998 shares of the technology company’s stock worth $57,477,000 after purchasing an additional 42,501 shares during the period. Finally, Victory Capital Management Inc. boosted its position in Plexus by 130.0% during the fourth quarter. Victory Capital Management Inc. now owns 349,057 shares of the technology company’s stock worth $51,311,000 after purchasing an additional 197,283 shares during the period. Institutional investors own 94.45% of the company’s stock.

Trending Headlines about Plexus

Here are the key news stories impacting Plexus this week:

  • Positive Sentiment: Quarterly results exceeded expectations. Plexus reported non-GAAP EPS of $2.32, beating consensus by $0.18, while revenue reached approximately $1.30 billion—about $80 million above estimates. Revenue increased 28.1% year over year to $1.31 billion, and gross profit rose 27.2% to $131.4 million. Plexus Non-GAAP EPS and Revenue Results
  • Positive Sentiment: Fourth-quarter guidance was well above earnings expectations. Management forecast EPS of $2.47–$2.63, compared with the $2.09 analyst consensus, and projected revenue of $1.3–$1.4 billion. The outlook suggests continued demand and potentially improving profitability. Plexus Fiscal Third Quarter Financial Results
  • Positive Sentiment: Operating profit rose 14.3% to $61.3 million, while cash and equivalents increased 32.2% year over year to $314.1 million. Recent analyst coverage also remains favorable, with a median price target of $310 and targets as high as $330, although these estimates may not yet reflect the latest results. Plexus Stock and Q3 2026 Earnings
  • Neutral Sentiment: Despite higher revenue and operating profit, net income attributable to common shareholders declined 4.7% to $43.0 million, and diluted GAAP EPS fell to $1.58. Total liabilities rose to $2.1 billion, while operating cash flow of $25.9 million was roughly offset by $26.7 million of capital spending.
  • Negative Sentiment: Insiders reported 43 open-market sales and no purchases over the past six months, including substantial sales by the CEO and other senior executives. This may raise valuation or confidence concerns, particularly after the stock’s strong longer-term advance. Plexus Insider Trading Activity

Analyst Upgrades and Downgrades

Several research firms have weighed in on PLXS. Needham & Company LLC boosted their price objective on Plexus from $285.00 to $310.00 and gave the stock a “buy” rating in a research report on Monday, June 1st. Zacks Research raised Plexus from a “strong sell” rating to a “hold” rating in a research report on Monday, July 13th. Stifel Nicolaus lifted their target price on Plexus from $280.00 to $330.00 and gave the stock a “buy” rating in a research note on Monday, June 22nd. Wall Street Zen raised shares of Plexus from a “hold” rating to a “buy” rating in a report on Saturday, May 2nd. Finally, Weiss Ratings upgraded shares of Plexus from a “buy (b-)” rating to a “buy (b)” rating in a research report on Monday, July 6th. Five research analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the company. According to MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $246.67.

View Our Latest Analysis on PLXS

Plexus Company Profile

(Get Free Report)

Plexus Corp. (NASDAQ: PLXS) is a global provider of electronics manufacturing services (EMS) and precision engineered electronics solutions. Headquartered in Neenah, Wisconsin, the company partners with original equipment manufacturers across industries such as medical, industrial, aerospace and defense, computing, and communications. Plexus offers a full suite of services that span new product introduction, product lifecycle management, supply chain management, printed circuit board assembly, system integration, and aftermarket support.

Founded in 1979, Plexus has grown from a regional electronics assembler into a multinational organization with manufacturing and engineering centers across North America, Europe, and Asia.

Featured Stories